Skip to main content
Top
Published in: Pathology & Oncology Research 2/2018

01-04-2018 | Research

RETRACTED ARTICLE: Impact of Toll-Like Receptors 2/3/4/9, IL-1-α/β and TNF-α Polymorphisms in Cervical Cancer Susceptibility in Tunisia

Genetic polymorphisms implicated in the occurence of Cervical Cancer

Authors: Sabrina Zidi, Hasibe Verdi, Yaprak Yilmaz-Yalcin, A. C. Yazici, Ezzedine Gazouani, Amel Mezlini, Fatma-Belgin Atac, Besma Yacoubi-Loueslati

Published in: Pathology & Oncology Research | Issue 2/2018

Login to get access

Excerpt

This article published in Pathology and Oncology Research, has been retracted at the request of Editor-in-Chief and the authors Hasibe Verdi, Yaprak Yilmaz-Yalcin, A. C. Yazici and Fatma-Belgin Atac. The reasons for the retraction of the article are:
  • There are substantial parts in the article that were previously published in the article: “Involvement of Toll-like receptors in cervical cancer susceptibility among Tunisian women” by Sabrina Zidi, Hasibe Verdi, Yaprak Yilmaz-Yalcin, A.C. Yazici, Ezzedine Gazouani, Amel Mezlini, Fatma-Belgin Atac, Besma Yacoubi-Loueslati, Bulletin du Cancer, 2014; 101: E31-E35, DOI: 10.​1684/​bdc.​2014.​2037. Although the article published in Pathology and Oncology Research uses a larger control group the two papers have very similar content, addressing the same problem with the same methodology and the differences in the articles were considered too minor.
  • In addition, this article was submitted to Pathology and Oncology Research without the knowledge or consent of all the authors.
Metadata
Title
RETRACTED ARTICLE: Impact of Toll-Like Receptors 2/3/4/9, IL-1-α/β and TNF-α Polymorphisms in Cervical Cancer Susceptibility in Tunisia
Genetic polymorphisms implicated in the occurence of Cervical Cancer
Authors
Sabrina Zidi
Hasibe Verdi
Yaprak Yilmaz-Yalcin
A. C. Yazici
Ezzedine Gazouani
Amel Mezlini
Fatma-Belgin Atac
Besma Yacoubi-Loueslati
Publication date
01-04-2018
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 2/2018
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-014-9793-7

Other articles of this Issue 2/2018

Pathology & Oncology Research 2/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine